176 related articles for article (PubMed ID: 34796432)
1. Tasquinimod efficacy and S100A9 expression in glucose-treated HREC cells.
Jin J; Zhang J; Bu S
Int Ophthalmol; 2022 Feb; 42(2):661-676. PubMed ID: 34796432
[TBL] [Abstract][Full Text] [Related]
2. YAP/TAZ Signaling Enhances Angiogenesis of Retinal Microvascular Endothelial Cells in a High-Glucose Environment.
Wang XL; Xian Y; Chen XL
Curr Eye Res; 2024 May; 49(5):524-532. PubMed ID: 38305219
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin22-52 suppresses high-glucose-induced migration, proliferation, and tube formation of human retinal endothelial cells.
Chen Z; Liu G; Xiao Y; Lu P
Mol Vis; 2014; 20():259-69. PubMed ID: 24623968
[TBL] [Abstract][Full Text] [Related]
4. Effect of miR-200b on retinal endothelial cell function under high glucose environment.
Jiang Q; Zhao F; Liu X; Li R; Liu J
Int J Clin Exp Pathol; 2015; 8(9):10482-7. PubMed ID: 26617758
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin alleviates DR retinal endothelial injury by regulating HMGB-1/NF-κB pathway.
Zhu Y; Li XY; Wang J; Zhu YG
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5535-5541. PubMed ID: 31298304
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FENDRR promotes high-glucose-induced proliferation and angiogenesis of human retinal endothelial cells.
Shi Y; Chen C; Xu Y; Liu Y; Zhang H; Liu Y
Biosci Biotechnol Biochem; 2019 May; 83(5):869-875. PubMed ID: 30700211
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation.
Yuan L; Hu J; Luo Y; Liu Q; Li T; Parish CR; Freeman C; Zhu X; Ma W; Hu X; Yu H; Tang S
Mol Vis; 2012; 18():1684-95. PubMed ID: 22773906
[TBL] [Abstract][Full Text] [Related]
8. The Suppression of Kallistatin on High-Glucose-Induced Proliferation of Retinal Endothelial Cells in Diabetic Retinopathy.
Xing Q; Zhang G; Kang L; Wu J; Chen H; Liu G; Zhu R; Guan H; Lu P
Ophthalmic Res; 2017; 57(3):141-149. PubMed ID: 27537690
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate protects retinal vascular endothelial cells from high glucose stress in vitro via the MAPK/ERK-VEGF pathway.
Zhang L; Zhang ZK; Liang S
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323164
[TBL] [Abstract][Full Text] [Related]
11. Kaempferol inhibited VEGF and PGF expression and in vitro angiogenesis of HRECs under diabetic-like environment.
Xu XH; Zhao C; Peng Q; Xie P; Liu QH
Braz J Med Biol Res; 2017 Mar; 50(3):e5396. PubMed ID: 28273207
[TBL] [Abstract][Full Text] [Related]
12. Connexin 43 (Cx43) regulates high-glucose-induced retinal endothelial cell angiogenesis and retinal neovascularization.
Shi W; Meng Z; Luo J
Front Endocrinol (Lausanne); 2022; 13():909207. PubMed ID: 36120455
[TBL] [Abstract][Full Text] [Related]
13. miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.
Liu X; Li J; Li X
Int J Immunopathol Pharmacol; 2020; 34():2058738420909041. PubMed ID: 32116075
[TBL] [Abstract][Full Text] [Related]
14. Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling.
Long L; Li Y; Yu S; Li X; Hu Y; Long T; Wang L; Li W; Ye X; Ke Z; Xiao H
J Diabetes Res; 2019; 2019():4875421. PubMed ID: 31976335
[TBL] [Abstract][Full Text] [Related]
15. Celastrol inhibits the proliferation and angiogenesis of high glucose-induced human retinal endothelial cells.
Fang J; Chang X
Biomed Eng Online; 2021 Jun; 20(1):65. PubMed ID: 34193168
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SNHG7 inhibits high glucose-induced human retinal endothelial cells angiogenesis by regulating miR-543/SIRT1 axis.
Ke N; Pi LH; Liu Q; Chen L
Biochem Biophys Res Commun; 2019 Jun; 514(2):503-509. PubMed ID: 31056258
[TBL] [Abstract][Full Text] [Related]
17. MiR-20b targets AKT3 and modulates vascular endothelial growth factor-mediated changes in diabetic retinopathy.
Qin B; Liu J; Liu S; Li B; Ren J
Acta Biochim Biophys Sin (Shanghai); 2016 Aug; 48(8):732-40. PubMed ID: 27421659
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-Interacting Protein Inhibited Vascular Endothelial Cell-Induced HREC Angiogenesis Treatment of Diabetic Retinopathy.
Yan J; Deng J; Cheng F; Zhang T; Deng Y; Cai Y; Cong W
Appl Biochem Biotechnol; 2023 Feb; 195(2):1268-1283. PubMed ID: 36346561
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin represses neovascularization in diabetic retinopathy.
Shao J; Yao Y
Mol Vis; 2016; 22():1188-1197. PubMed ID: 27746673
[TBL] [Abstract][Full Text] [Related]
20. Effects of 5-aza-2'-deoxycytidine and trichostatin A on high glucose- and interleukin-1β-induced secretory mediators from human retinal endothelial cells and retinal pigment epithelial cells.
Xie M; Tian J; Luo Y; Wei L; Lin S; Tang S
Mol Vis; 2014; 20():1411-21. PubMed ID: 25352747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
